Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci.
Authors:
Open Access
- 1 November 1991
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 174 (5) , 1255-1258
Abstract
Superantigens are defined by their ability to stimulate T cells based predominantly on their V beta expression and ability to delete T cells in the thymus when expressed endogenously. We show here that the expression of one endogenous superantigen, Etc-1, is controlled by the expression of the open reading frame region of the 3' long terminal repeat of the mouse mammary tumor proviral gene, Mtv-9. We show that Mtv-8 controls a superantigen with similar specificity, and that both Mtv-8 and Mtv-9 stimulate some V beta 17+ T cells. A third provirus, Mtv-6, controls a superantigen with specificity for V beta 3. Data presented raise the possibility that endogenous superantigens may compete for class II molecules in a single B cell.Keywords
This publication has 15 references indexed in Scilit:
- Superantigens: Mechanism of T-Cell Stimulation and Role in Immune ResponsesAnnual Review of Immunology, 1991
- Clonal deletion of V β814-bearing T cells in mice transgenic for mammary tumour virusNature, 1991
- A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virusNature, 1991
- Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomesNature, 1991
- An endogenous retrovirus mediating deletion of αβ T cells?Nature, 1991
- Linkage of Mls genes to endogenous mammary tumour viruses of inbred miceNature, 1991
- A maternally inherited superantigen encoded by a mammary tumour virusNature, 1991
- Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9 .The Journal of Immunology, 1990
- Requirement for Cotolerogenic Gene Products in the Clonal Deletion of I-E Reactive T CellsScience, 1990
- Molecular genetic analysis of 178 I-Abm12-reactive T cells.Journal of Experimental Medicine, 1989